GlassScriptPhysician profile
Danielle Marie Jacobson
NPI 1528552122
$465.15
in general payments reported to CMS, 2019-2025
12 companies · $44.42 in 2025
The $44.42 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2022: $54.19 · 2023: $92.83 · 2024: $154 · 2025: $44.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $290.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.84 | 2022-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $79.68 | 2021-2024 | Eliquis |
| Merck Sharp & Dohme LLC | $73.89 | 2024-2025 | Zerbaxa, Dificid, Recarbrio |
| Abbvie INC. | $64.25 | 2024 | |
| Novo Nordisk INC | $32.32 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $25.30 | 2024 | |
| Janssen Pharmaceuticals, INC | $23.03 | 2022 | |
| Medtronic, INC. | $19.04 | 2023 | Linq II |
| Alexion Pharmaceuticals, INC. | $18.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.94 | 2021 | |
| Gilead Sciences, INC. | $14.20 | 2021 | |
| Boston Scientific Corporation | $13.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Jacobson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.